login
login

Europe Daily Bulletin No. 13035

5 October 2022
Contents Publication in full By article 29 / 36
EU RESPONSE TO COVID-19 / Health
Review of suitable vaccine for children and standardisation of authorisation of two Covid-19 mRNA vaccines
Brussels, 04/10/2022 (Agence Europe)

There are developments in the European Union’s vaccine strategy with two recent announcements.

The European Medicines Agency (EMA) announced on Monday 3 October that it had started a ‘rolling review’ of the Pfizer-BioNTech messenger RNA vaccineComirnaty against the original SARS-CoV-2 strain and the sub-variants of concern BA.4 and BA.5 (see EUROPE B13020A31) for use in children aged 5-11 years.

Furthermore, as the efficacy and safety of the two messenger RNA vaccines against...

Contents

EUROPEAN PARLIAMENT PLENARY
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
SECURITY - DEFENCE
EXTERNAL ACTION
SECTORAL POLICIES
SOCIAL AFFAIRS
EU RESPONSE TO COVID-19
NEWS BRIEFS